To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Sofinnova wraps up crossover fund at $540m
Sofinnova Partners, a European life sciences venture firm, has closed its crossover fund at $540 million.
